KAFFI 1gm by Chemisis Pharmaceuticals contains Ceftriaxone, a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. Ceftriaxone is effective against various gram-positive and gram-negative bacteria, making it useful for treating infections such as respiratory tract infections, urinary tract infections, skin infections, septicemia, meningitis, and sexually transmitted infections like gonorrhea. Ceftriaxone works by inhibiting the synthesis of the bacterial cell wall, leading to cell lysis and death. It is administered via intramuscular or intravenous injection, typically in a clinical or hospital setting. The dosage and duration of treatment depend on the type and severity of the infection, the patient’s age, and kidney function. Common side effects of KAFFI 1gm may include pain or swelling at the injection site, rash, diarrhea, nausea, and headache. Serious side effects are rare but can include severe allergic reactions, Clostridium difficile-associated diarrhea, and changes in blood cell counts. Patients should inform their healthcare provider of any allergies or pre-existing conditions before starting treatment.